Organometallics · 2019 · 37 citations · 55 references
MedicineOncologyPharmacologyCancer PharmacologyMolecular OncologySteroid BiochemistryBioinorganic ChemistryBreast Cancer PharmacotherapyEnzyme InhibitionLigand BindingMolecular Mechanisms Of ToxicityAnticancer Compound ScreeningAromatase ActivityAromatase InhibitionAromatase InhibitorsChemical Structure-activity RelationshipsCytotoxicity AssaysEmbryo Culture MediaMedicinal Chemistry Applications
Third-generation aromatase inhibitors such as anastrozole (ATZ) and letrozole (LTZ) are widely used to treat estrogen receptor-positive (ER+) breast cancers in postmenopausal women. Investigating their ability to coordinate metals could lead to the emergence of a new category of anticancer drug candidates with a broader spectrum of pharmacological activities. In this study, a series of ruthenium(II) arene complexes bearing the aromatase inhibitor anastrozole was synthesized and characterized. Among these complexes, [Ru(η6-C6H6)(PPh3)(η1-ATZ)Cl]BPh4 (3) was found to be the most stable in cell culture media, to lead to the highest cellular uptake and in vitro cytotoxicity in two ER+ human breast cancer cell lines (MCF7 and T47D), and to induce a decrease in aromatase activity in H295R cells. Exposure of zebrafish embryos to complex 3 (12.5 μM) did not lead to noticeable signs of toxicity over 96 h, making it a suitable candidate for further in vivo investigations.
55
A short history of<i>SHELX</i>
George M. Sheldrick · Acta Crystallographica Section A Foundations of Crystallography · 2007 · 87.4K citations · Full text
Stages of embryonic development of the zebrafish
Charles B. Kimmel, William W. Ballard, Seth R. Kimmel et al. · Developmental Dynamics · 1995 · 12.3K citations